These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Evaluation of efficacy of treatment for 30 children with neuroblastoma]. Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065 [TBL] [Abstract][Full Text] [Related]
7. Drug trials in neuroblastoma: cyclophosphamide (NSC-26271) alone; vincristine (NSC-67574) plus cyclophosphamide; 6-mercaptopurine (NSC-755) plus 6-methylmercaptopurine riboside (NSC-40774); and cytosine arabinoside (NSC-63878) alone. Starling KA; Sutow WW; Donaldson MH; Land VJ; Lane DM Cancer Chemother Rep; 1974; 58(5 Pt 1):683-8. PubMed ID: 4426047 [No Abstract] [Full Text] [Related]
9. A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomas. Creagan ET; Edmonson JH; Hahn RG; Ahmann DL; Bisel HF; Eagan RT Med Pediatr Oncol; 1978; 4(1):85-6. PubMed ID: 625266 [TBL] [Abstract][Full Text] [Related]
10. Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: effects upon immunological function. Ekert H; Jose DG; Wilson FC; Matthews RN; Lay H Int J Cancer; 1975 Jul; 16(1):103-12. PubMed ID: 1058172 [TBL] [Abstract][Full Text] [Related]
11. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma. Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers. Cunningham TJ; Antemann R; Paonessa D; Sponzo RW; Steiner D Ann N Y Acad Sci; 1976; 277(00):339-44. PubMed ID: 1069553 [No Abstract] [Full Text] [Related]
13. [Therapy and prognosis of neuroblastoma. Report of 54 cases observed in Switzerland]. Taminelli F; Käser H; Wagner HP Helv Paediatr Acta; 1970 Dec; 25(6):554-65. PubMed ID: 5515939 [No Abstract] [Full Text] [Related]
14. A rationale for the treatment of metastatic neuroblastoma. Helson L; Helson C; Peterson RF; Das SK J Natl Cancer Inst; 1976 Sep; 57(3):727-9. PubMed ID: 185404 [TBL] [Abstract][Full Text] [Related]
15. [Combined chemotherapy of neuroblastoma. 1st results in 40 children with metastatic form]. Zucker JM; Mercier JC Arch Fr Pediatr; 1976; 33(6):555-67. PubMed ID: 949221 [TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma. Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111 [TBL] [Abstract][Full Text] [Related]
18. [Neuroblastoma study NBL79-society of pediatric oncology -- report after 1 year (author's transl)]. Berthold F; Treuner J; Niethammer D; Lampert F Klin Padiatr; 1981 May; 193(3):198-201. PubMed ID: 6167757 [TBL] [Abstract][Full Text] [Related]
19. [Survival of children and results obtained with a new chemotherapic combination in disseminated neuroblastoma treatment (author's transl)]. Padulles J; Prats J; Martínez-Mora J; Boix Ochoa J; Ferres F An Esp Pediatr; 1976 Nov; 9(8):33-5. PubMed ID: 65139 [TBL] [Abstract][Full Text] [Related]